NEW INSIGHTS IN METASTATIC COLORECTAL CANCER TREATMENT (MCRC) IN 5 EUROPEAN COUNTRIES

被引：0
|
作者：
Kolb, N. [1 ]
Reichert, A. [1 ]
Menacher, G. [1 ]
Mambrini, T. [1 ]
von Bredow, D. [1 ]
机构：
[1] QuintilesIMS, Munich, Germany
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 09期
关键词：
D O I：
10.1016/j.jval.2017.08.371
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN288
引用
收藏
页码：A464 / A464
页数：1
相关论文
共 50 条
  • [31] BUDGET IMPACT ANALYSIS OF AFLIBERCEPT IN YHE TREATMENT OF METASTATIC COLORECTAL CANCER (MCRC) IN POLAND
    Kaczor, M. P.
    Pawlik, D.
    Wojcik, R.
    Glasek, M.
    Pieczonka, A.
    Kraska, A.
    Zelazowski, K.
    VALUE IN HEALTH, 2014, 17 (07) : A621 - A621
  • [32] Characteristics and treatment effect of senior patients with metastatic colorectal cancer (mCRC): A retrospective analysis
    Boudreault, J.
    Aubin, F.
    Ayoub, J. M.
    Sylvestre, M.
    Richard, C. S.
    Tehfe, M. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [33] Capecitabine and oxaliplatin (XELOX) as first line treatment for patients with metastatic colorectal cancer (MCRC)
    Karacetin, D.
    Maral, O.
    Yalcyn, B.
    Okten, B.
    Incekara, O.
    ANNALS OF ONCOLOGY, 2006, 17 : 73 - 73
  • [34] Predictive profiling of 5-fluorouracil (5-FU) resistance in metastatic colorectal cancer (mCRC).
    Ichikawa, W
    Takahashi, T
    Suto, K
    Okayama, Y
    Toda, E
    Oka, T
    Okayama, S
    Hirayama, R
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 261S - 261S
  • [35] Identification and validation of a new prognostic score in metastatic colorectal cancer (mCRC): GEMCAD score
    Segui, E.
    Alonso-Orduna, V.
    Sesma, A.
    Martin-Richard, M.
    Salud, A.
    Fernandez-Montes, A.
    Fernandez-Martos, C.
    Ruiz-Casado, A.
    Gallego, J.
    Aparicio, J.
    Galvez, E.
    Manzano, H.
    Alcaide-Garcia, J.
    Gallego, R.
    Falco, E.
    Esposito, F.
    Oliveres, H.
    Torres, F.
    Feliu, J.
    Maurel, J.
    ANNALS OF ONCOLOGY, 2020, 31 : S441 - S441
  • [36] New treatment combination for metastatic colorectal cancer
    Nature Reviews Gastroenterology & Hepatology, 2014, 11 (12) : 702 - 702
  • [37] New drugs for the treatment of metastatic colorectal cancer
    Cherri, Sara
    Libertini, Michela
    Zaniboni, Alberto
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2021, 13 (11) : 1551 - 1560
  • [38] RET rearrangements define a new and rare molecular subtype of metastatic colorectal cancer (mCRC)
    Filippo, Pietrantonio
    Alexa, Schrock
    Lee Jeeyun
    Alexander, Drilon
    Jason, Christiansen
    Vi, Chiu
    Giovanni, Fuca
    Federica, Morano
    Daniele, Rossini
    Tae, Kim Seung
    Massimo, Milione
    Rupal, Patel
    Vincent, Miller
    Michele, Prisciandaro
    Maria, Di Bartolomeo
    Jeffrey, Ross
    Andrea, Bertotti
    Siraj, Ali
    Livio, Trusolino
    Alfredo, Falcone
    Filippo, de Braud
    Chiara, Cremolini
    ANNALS OF ONCOLOGY, 2017, 28
  • [39] New drugs for the treatment of metastatic colorectal cancer
    Sara Cherri
    Michela Libertini
    Alberto Zaniboni
    World Journal of Gastrointestinal Oncology, 2021, (11) : 1551 - 1560
  • [40] QUALITY OF LIFE OF PATIENTS LIVING WITH METASTATIC COLORECTAL CANCER (MCRC): EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER (EORTC) QUESTIONNAIRE RESULTS FROM A REAL WORLD EUROPEAN SURVEY
    Benedict, A.
    Rakonczai, P.
    Muszbek, N.
    Maravic, Z.
    VALUE IN HEALTH, 2018, 21 : S80 - S80
12345